Share this article
Share this article
LINKÖPING, Sweden, Jan. 12, 2021 /PRNewswire/ -- A perspective review article titled "Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis" was recently published in
Frontiers in Endocrinology as part of a special issue of "Non-Alcoholic Steatohepatitis (NASH)—Metabolic Contributors and Therapeutic Targets." Authored by scientific experts from Axcella Health, AMRA Medical, Linköping University, and Virginia Commonwealth University (VCU), this paper describes the link between muscle composition and chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD). It discusses in depth the scientific basis of underlying factors outside of the liver to treat NAFLD – affecting nearly one-quarter of the world's adult population.